Results 151 to 160 of about 83,381 (315)
In hemophilia B, pharmacokinetic (PK)‐guided dosing of extended half‐life factor IX (EHL‐FIX) concentrates can secure targeted FIX exposure. Target FIX activity levels in plasma should be individually set primarily taking bleeding tendency into account, alongside the presence of target joints, physical activity, and preferred dosing schedules. In other
Sjoerd F. Koopman +4 more
wiley +1 more source
A Story Worth Telling: The Evolution of Haemophilia Care in Canada
Haemophilia, EarlyView.
Kelsey Uminski, Adrienne Lee
wiley +1 more source
Overview of Patients with Hemophilia in China: Demographics, Diseases, Treatment, and Health Status
Luying Zhang,1,* Peng Zhang,2,* Wen Chen1 1School of Public Health, Fudan University, Shanghai, 200032, People’s Republic of China; 2School of Humanities, Shanghai Institute of Technology, Shanghai, 201418, People’s Republic of China*These ...
Zhang L, Zhang P, Chen W
doaj
Background and Aims: Intracerebral hemorrhage (ICH) is a severe and life-threatening complication in patients with hemophilia, often resulting in high mortality and long-term neurological impairment.
doaj +1 more source
Endoscopic Vascular Grading Directs Stepwise Therapy in Hereditary Hemorrhagic Telangiectasia
This study introduces a novel endoscopic vascular grading system for HHT. The system is inspired by intergenerational family observations and correlates with epistaxis severity. It guides personalized therapy based on grade, offering simplicity and clinical utility.
Hong‐Gang Duan +5 more
wiley +1 more source
The Role of the Consumer-Patient in the Growth of a Comprehensive Hemophilia Care Unit [PDF]
Dorothy Child +2 more
openalex +1 more source
ABSTRACT Purpose Vitamin K deficiency bleeding (VKDB) can occur in neonates and infants due to low placental transfer and storage of VK. Although the incidence has decreased with global VK prophylaxis at birth, VKDB remains a concern. This study aimed to assess the recent magnitude, risk factors, and outcomes of VKDB and barriers/limitations to VK ...
Nongnuch Sirachainan +16 more
wiley +1 more source
PB2654: RARE BLEEDING DISORDERS: LONG-TERM EXPERIENCE FROM A HEMOPHILIA CENTER
Antonios Meimaridis +5 more
doaj +1 more source
Hereditary Hemorrhagic Disorders Excluding Hemophilia Group
Mitsuyasu Kagami
openalex +2 more sources

